An antithrombotic agent is a drug that reduces the formation of blood clots. Antithrombotics could be used therapeutically for prevention (primary prevention, secondary prevention) or treatment of a dangerous blood clot (Acute thrombus).
Antithrombotic is a drug that helps reduce thrombus formation. Different antithrombotics affect different blood clotting processes like antiplatelet drugs, anticoagulants, and thrombolytic drugs. Its main application is to treat the abnormal blood flow in the human body.
The major causes of thrombosis are inactivity, blood vessel damage, medical and genetic conditions, pregnancy, obesity, and smoking. With the growing population across the globe, the demand for such life savings drugs is bound to increase.
Access research report on global antiplatelet/antithrombotic market: http://www.grandviewresearch.com/industry-analysis/antiplatelet-antithrombotic-market
An antiplatelet drug is a member of a class of pharmaceuticals that decrease platelet aggregation and inhibit thrombus formation. They are effective in the arterial circulation. They are widely used in primary and secondary prevention of thrombotic cerebrovascular or cardiovascular disease.
The major drivers for this market are factors such as the proliferation of antithrombotic/anticoagulant drugs, increasing aging population, an increase in thrombotic events, and recent advances in pharmaceuticals.
Related reports by Grand View Research:
Antithrombotic drugs, which include anticoagulants, antiplatelate drugs, and thrombolytic drugs, are used in wide range of indication for the prevention and treatment of ischemic events. These include acute coronary syndrome (ACS), myocardial infarction (MI), and stroke, venous thromboembolism (VTE) and peripheral occlusion (PAO).
Antiplatelet (Antithrombotic) Market is segmented on the basis of different blood clot processes as follows:
Antiplatelet drugs- They limit the migration or aggregation of platelets. Antiplatelet drug decreases the ability of blood clot to form by interfering with platelet activation process in primary homeostasis. Antiplatelet drugs can reversibly or irreversibly inhibit the process involved in platelet activation resulting in decreased tendency of platelets to adhere to one another and damaged blood vessels endothelium.
Read Our Blogs –grandviewresearch.com/blogs/healthcare
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
Corporate Sales Specialist, USA
Grand View Research, Inc
Toll Free: 1-888-202-9519
For more information: www.grandviewresearch.com